TIMP1 and Sepsis: In conclusion, the novel findings of our study were that non-surviving septic patients showed persistently higher TIMP-1/MMP-9 ratio than survivors during the first week, which was associated with severity, coagulation state, circulating cytokine levels and mortality, thus representing a new biomarker of sepsis outcome.